Loading organizations...
Loading organizations...
Shulan Health has raised $39.0M across 2 funding rounds.
Shulan Health has raised $39.0M in total across 2 funding rounds.
Shulan Health has raised $39.0M in total across 2 funding rounds.
Shulan Health's investors include Qiming Venture Partners.
Shulan Health is a technology-driven healthcare group based in China that integrates healthcare services, medical research, and education. It operates hospitals and medical centers offering services such as rehabilitation, nutrition, health examinations, and remote consultations. The company builds internet-based medical information platforms designed to support large hospital groups and their patients, addressing the need for integrated, technology-enabled healthcare delivery. Shulan Health aims to solve challenges related to healthcare accessibility, quality, and coordination, leveraging technology to enhance patient care and medical research. The company is currently in a growth phase, having submitted a pre-IPO listing application to the Hong Kong Stock Exchange to accelerate its expansion[1][2][3][4][5].
Founded in 2013 in China, Shulan Health emerged from the vision to combine healthcare services with medical scientific research and education, creating a comprehensive healthcare ecosystem. The founders and key leaders focused on integrating technology with traditional medical services to improve healthcare delivery. Early traction included building a network of hospitals and medical centers supported by technology platforms that facilitate patient management and remote consultations. The company’s evolution reflects a strategic shift toward becoming a leading technology-based social medical group in China, with significant involvement in critical and serious diseases[3][4].
Shulan Health rides the global trend of digital transformation in healthcare, where technology integration is crucial for improving patient outcomes and operational efficiency. The timing is favorable due to increasing demand for accessible, high-quality healthcare services in China and the broader Asia region, coupled with government support for healthcare innovation. Market forces such as aging populations, rising chronic diseases, and the need for remote healthcare solutions amplify the company’s relevance. By integrating medical research and education with healthcare delivery, Shulan Health influences the broader ecosystem by fostering innovation and setting standards for technology-enabled healthcare services[1][3][4].
Shulan Health’s next phase likely involves scaling its technology platforms and expanding its hospital network post-IPO to capture a larger share of China’s growing healthcare market. Trends such as AI-driven diagnostics, telemedicine, and personalized medicine will shape its journey, enabling more precise and accessible care. Its influence may evolve from a regional healthcare provider to a leading innovator in integrated medical services, potentially expanding internationally. The company’s success will depend on balancing technology adoption with quality medical care and navigating regulatory environments in China and beyond[1][3][4].
Shulan Health has raised $39.0M across 2 funding rounds. Most recently, it raised $8.0M Series C in March 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 1, 2020 | $8.0M Series C | Qiming Venture Partners | |
| Nov 1, 2016 | $31.0M Series B | Qiming Venture Partners |
